Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-20 Purchase | 2025-10-21 5:43 pm | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 20,000 | $13.64 | $272,790 | 949,674 (Indirect Direct) | View |
| 2025-10-17 Purchase | 2025-10-20 4:44 pm | MBX Biosciences Inc. | MBX | Hoerter Steven L. Director | 20,000 | $13.25 | $264,984 | 20,000 (Indirect) | View |
| 2025-09-26 Purchase | 2025-09-30 4:59 pm | MBX Biosciences Inc. | MBX | Heron Patrick J FHMLS X L.P. FHMLS X L.L.C. Topper James N Frazier Life Sciences X L.P. Director 10% Owner | 666,666 | $18 | $11,999,988 | 5,219,440 (Indirect) | View |
| 2025-04-08 Purchase | 2025-04-10 08:39 am | MBX Biosciences Inc. | MBX | Pescovitz Ora H. Director | 7,693 | $5.89 | $45,312 | 24,329 (Direct) | View |
| 2025-02-14 Purchase | 2025-02-19 5:56 pm | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) | View |
| 2025-02-14 Purchase | 2025-02-19 5:52 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) | View |
| 2025-02-04 Purchase | 2025-02-05 4:17 pm | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 50,000 | $10.69 | $534,500 | 1,172,674 (Indirect Direct) | View |
| 2024-09-16 Purchase | 2024-09-17 8:28 pm | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:26 pm | MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:24 pm | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:23 pm | MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:21 pm | MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:20 pm | MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:18 pm | MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:17 pm | MBX Biosciences Inc. | MBX | Yang Rick 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:14 pm | MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:13 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:12 pm | MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Direct) | View |
| 2024-09-16 Purchase | 2024-09-17 8:11 pm | MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner | 625,000 | $16 | $10,000,000 | 4,552,774 (Direct) | View |
| 2024-09-16 Purchase | 2024-09-17 8:09 pm | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 625,000 | $16 | $10,000,000 | 4,552,774 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-03 4:16 pm | N/A 2036-02-02 | MBX Biosciences Inc. | MBX | Azoulay Salomon Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 4:16 pm | N/A 2036-02-02 | MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 4:16 pm | N/A 2036-02-02 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 199,750 | $0 | 1,332,283 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-22 08:08 am | N/A 2036-01-20 | MBX Biosciences Inc. | MBX | Stelzer Laurie Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-11-22 Option Award | 2025-11-25 08:50 am | N/A 2035-11-21 | MBX Biosciences Inc. | MBX | Hoerter Steven L. Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 08:20 am | N/A 2035-11-05 | MBX Biosciences Inc. | MBX | Hoerter Steven L. Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-10-24 Exercise | 2025-10-28 08:03 am | 2022-11-07 2032-11-06 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 182,859 | $0 | 1,262,241 (Direct) | View |
| 2025-10-24 Exercise | 2025-10-28 08:03 am | N/A N/A | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 182,859 | $3.25 | 1,262,241 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 11:29 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:59 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Hoerter Steven L. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:05 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Aynechi Tiba Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:04 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:03 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Ryder Steven Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:02 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 08:01 am | N/A 2035-06-05 | MBX Biosciences Inc. | MBX | Pescovitz Ora H. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-04-07 Option Award | 2025-04-09 08:27 am | N/A 2035-04-07 | MBX Biosciences Inc. | MBX | Hoerter Steven L. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:17 pm | N/A 2035-02-03 | MBX Biosciences Inc. | MBX | Azoulay Salomon Chief Medical Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:17 pm | N/A 2035-02-03 | MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:17 pm | N/A 2035-02-03 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 243,000 | $0 | 1,172,674 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:28 pm | N/A N/A | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:26 pm | N/A N/A | MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:24 pm | N/A N/A | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:23 pm | N/A N/A | MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:21 pm | N/A N/A | MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:20 pm | N/A N/A | MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:18 pm | N/A N/A | MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:17 pm | N/A N/A | MBX Biosciences Inc. | MBX | Yang Rick 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:12 pm | N/A N/A | MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 40,557,180 | $0 | 3,614,486 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:11 pm | N/A N/A | MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner | 51,147,891 | $0 | 4,552,774 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:11 pm | N/A N/A | MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director | 1,329,343 | $0 | 102,082 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:09 pm | N/A N/A | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 51,147,891 | $0 | 4,552,774 (Indirect) | View |